Key result
Age and elevated inflammatory markers are linked to cardiac injury in geriatric COVID-19 patients.
Why the study?
Geriatric patients with COVID-19 are at high risk of cardiac injury, and identifying factors affecting high-sensitivity cardiac troponin I may clarify causes of cardiac injury in this population.
Cohort (n=180)
p-value: p=<0.001
In geriatric COVID-19 patients, cardiac injury is significantly associated with age and elevated inflammatory markers, suggesting inflammation plays a key role in myocardial damage.
May support cardiac risk monitoring in geriatric COVID-19; hypothesis-generating for inflammation-targeted prevention.
BACKGROUND: Geriatric patients with coronavirus disease (COVID-19) are at high risk of developing cardiac injury. Identifying the factors that affect high-sensitivity cardiac troponin I may indicate the cause of cardiac injury in elderly patients, and this could hopefully assist in protecting heart function in this patient population. METHODS: One hundred and eighty inpatients who were admitted for COVID-19 were screened. Patients older than 60 years were included in this study, and the clinical characteristics and laboratory results of the cohort were analyzed. The correlation between cardiac injury and clinical/laboratory variables was statistically analyzed, and further logistic regression was performed to determine how these variables influence cardiac injury in geriatric patients. RESULTS: Age (p < 0.001) significantly correlated with cardiac injury, whereas sex (p = 0.372) and coexisting diseases did not. Rising procalcitonin (p = 0.001), interleukin-2 receptor (p < 0.001), interleukin 6 (p = 0.001), interleukin 10 (p < 0.001), tumor necrosis factor α (p = 0.001), high-sensitivity C-reactive protein (p = 0.001), D-dimer (p < 0.001), white blood cells (p < 0.001), neutrophils (p = 0.001), declining lymphocytes (p < 0.001), and natural killer cells (p = 0.005) were associated with cardiac injury and showed predictive ability in the multivariate logistic regression. CONCLUSION: Our results suggest that age and inflammatory factors influence cardiac injury in elderly patients. Interfering with inflammation in this patient population may potentially confer cardiac protection.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2020) conducted a cohort in COVID-19 (n=180). Age and inflammatory factors was evaluated on Cardiac injury (p=<0.001). Age (p<0.001) and elevated inflammatory markers, including procalcitonin, IL-6, and D-dimer, were significantly associated with cardiac injury in geriatric COVID-19 patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: